A man sat looking at a laptop. He is smiling slightly and is wearing a red, collared shirt and glasses.

 

 

DETERMINE news hub

Discover our latest updates including updates on our progress, site openings, and partnership initiatives. 

Interested in learning more about the trial and how to get involved?

Find out more about DETERMINE

 

 

Our highlights

DETERMINE team winning bionow awards

The timelines to treating the 100th patients

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient.

Read about DETERMINE's successes
sky news DETERMINE

Patient finds hope with DETERMINE trial

Sky News covered the Target National genetic screening trial and spoke to Pamela Garner-Jones who was diagnosed with cervical cancer in 2021. Through TARGET National, Pamela was matched to a treatment on our DETERMINE trial and has since seen her tumour shrink by two thirds and symptoms improve.

Read about the patient's story
prime rose logo

Collaboration for implementation of precision cancer medicine in Europe

PCM4EU (Personalized Cancer Medicine for all EU citizens) and PRIME-ROSE (Precision Cancer Medicine Repurposing System Using Pragmatic Clinical Trials) aim to facilitate implementation of precision cancer medicine in Europe.

Read about the collaboration
Explore the PRIME-ROSE website